BioNexus companies reach almost RM2.2 billion in revenues

July 12, 2012 |

In Malaysia, Ministry of Sciences Malaysian Biotechnology Corp’s CEO Datuk Mohd Nazlee Kamal used the launch of ADT Biotech Sdn Bhd to comment on BioNexus’ progress, now 215 companies strong.

Kamal said, “Thus far, Malaysian BioNexus companies have demonstrated high value capital growth with a combined market capitalisation of over RM1.23 billion for the five listed BioNexus companies on the London Stock Exchange Alternative Investment Market, Australian Stock Exchange, and Bursa Malaysia. In terms of earnings to date, the combined total revenue of BioNexus companies is close to RM2.2 billion …At the same time, the BioNexus status has attracted both domestic-driven investment as well as foreign direct investment into Malaysia. The Malaysian biotechnology industry has managed to attract investors from the UK, France, Germany, Italy, Belgium, the US, India, China, Japan, Hong Kong, Singapore, Thailand, Australia and New Zealand, in all key focus areas such as agriculture biotechnology, healthcare biotechnology and industrial biotechnology.”

More on the story.

Print Friendly, PDF & Email


Category: Dashboard

Thank you for visting the Digest.